PLANT HEALTH CARE INC.
Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the Americas, Mexico, and internationally. It offers products to enhance the yield and quality of crops, such as corn, soybeans, citrus, sugar cane, and rice, as well as fruits and vegetables. The company provides Harpin a, a recombinant protein, which acts as a biostimulant to enhance the yield and quality of crops; and Saori, a vaccine for plants that promotes healthy growth of soybeans and helps them fight disease. It also distributes third-party biological products. The company was founded in 1995 and is headquartered in Holly Springs, North Carolina.
Country/Area ：United States
Company Email ：contact@cavendish.com
Industry ：BiotechnologyHealthcarePharmaceuticals
Company website ：*****
Company phone ：(919) 926-1600
Established ：1995
Company Revenue ：$10,487,000
Number of employees ：56
SIC Code ：28283
NAICS Code ：32325
Company News
Plant Health Care plc (LON:PHC): Is Breakeven Near?
Oct 6, 2023
Plant Health Care plc ( LON:PHC ) is possibly approaching a major achievement in its business, so we would like to...
Oct 6, 2023
Why Investors Shouldn't Be Surprised By Plant Health Care plc's (LON:PHC) P/SJun 13, 2023
When close to half the companies in the Chemicals industry in the United Kingdom have price-to-sales ratios (or "P/S...
Jun 13, 2023When Will Plant Health Care plc (LON:PHC) Become Profitable?Apr 28, 2023
Plant Health Care plc ( LON:PHC ) is possibly approaching a major achievement in its business, so we would like to...
Apr 28, 2023A number of insiders bought Plant Health Care plc (LON:PHC) stock last year, which is great news for shareholdersMar 18, 2023
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Mar 18, 2023A Plant Health Care plc (LON:PHC) insider increased their holdings by 17% last yearJul 1, 2022
Insiders were net buyers of Plant Health Care plc's ( LON:PHC ) stock during the past year. That is, insiders bought...
Jul 1, 2022Web Summary
Q1: What is the company name and its location?
A1: The company name is Plant Health Care Inc., and it has operations in more than 30 countries, with a presence in major producing regions such as the USA, Mexico, Brazil, and Europe.
Q2: What type of products does the company provide?
A2: Plant Health Care provides proprietary agricultural biological products and technology solutions focused on improving crop performance, including Harpinαβ, PHC279, Saori, and other peptide-based products.
Q3: What is the company's focus in terms of market access and revenue growth?
A3: The company aims to drive revenue by focusing on distribution of its products through large distributors with broad market access, particularly in broad acre crops and vegetables such as sugar cane, corn, soy, citrus, rice, almonds, and grapes.
Q4: What is the company's strategy for launching new products from its PREtec platforms?
A4: The company plans to launch at least one PREtec product in a major market every year, with recent launches including Saori in Brazil and PHC279 under the brand Obrona in the US corn and specialty crops market.
Q5: What is the company's approach to building capability for delivering additional products from its PREtec platforms?
A5: The company has invested in building a pilot plant facility in Seattle to produce peptides on a pilot scale, and secured a production facility for PHC279 to achieve volume cost targets.
Q6: How does the company protect its intellectual property (IP)?
A6: The company has an extensive library of PREtec peptides, with multiple patents granted by the USPTO and international patent offices, and numerous filings in progress around the world to further expand its IP portfolio.
Q7: What is the company's approach to sustainability and environmental responsibility?
A7: The company's products contribute to sustainable agriculture, with Harpinαβ and PREtec peptides classified as "low toxicity" products and exempt from maximum residue limits (MRLs), and eligible for 'fast track' regulatory approval in the USA and Brazil.
Q8: What is the company's growth strategy beyond its current focus?
A8: The company aims to consolidate the fragmented sector through its strong portfolio and market access, with a long-term vision to expand its presence and offerings in the agricultural biological products market.
A1: The company name is Plant Health Care Inc., and it has operations in more than 30 countries, with a presence in major producing regions such as the USA, Mexico, Brazil, and Europe.
Q2: What type of products does the company provide?
A2: Plant Health Care provides proprietary agricultural biological products and technology solutions focused on improving crop performance, including Harpinαβ, PHC279, Saori, and other peptide-based products.
Q3: What is the company's focus in terms of market access and revenue growth?
A3: The company aims to drive revenue by focusing on distribution of its products through large distributors with broad market access, particularly in broad acre crops and vegetables such as sugar cane, corn, soy, citrus, rice, almonds, and grapes.
Q4: What is the company's strategy for launching new products from its PREtec platforms?
A4: The company plans to launch at least one PREtec product in a major market every year, with recent launches including Saori in Brazil and PHC279 under the brand Obrona in the US corn and specialty crops market.
Q5: What is the company's approach to building capability for delivering additional products from its PREtec platforms?
A5: The company has invested in building a pilot plant facility in Seattle to produce peptides on a pilot scale, and secured a production facility for PHC279 to achieve volume cost targets.
Q6: How does the company protect its intellectual property (IP)?
A6: The company has an extensive library of PREtec peptides, with multiple patents granted by the USPTO and international patent offices, and numerous filings in progress around the world to further expand its IP portfolio.
Q7: What is the company's approach to sustainability and environmental responsibility?
A7: The company's products contribute to sustainable agriculture, with Harpinαβ and PREtec peptides classified as "low toxicity" products and exempt from maximum residue limits (MRLs), and eligible for 'fast track' regulatory approval in the USA and Brazil.
Q8: What is the company's growth strategy beyond its current focus?
A8: The company aims to consolidate the fragmented sector through its strong portfolio and market access, with a long-term vision to expand its presence and offerings in the agricultural biological products market.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
